Although it remains unclear why obesity improves the efficacy of PD-1 blockades in cancer patients, an in vivo study demonstrated that the frequency of PD-1 on tumor-infiltrating CD8+ T cells was significantly higher in obese mice than in control mice, and a PD-1 blockade was apparently effective in obese mice compared with control mice [28]. Here, CD8A is linked to cancer.